Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
Turning to turkey’s tryptophan to boost mood? Not so fast26.11.2025 - 2Step by step instructions to Pick A Keep money with High Fixed Store Loan costs06.06.2024
- 3Support Your Wellness: 20-Minute Home Exercises That Work11.08.2023
- 4Vote in favor of Your Number one Cake Type05.06.2024
- 5Exploring the Gig Economy: Examples from Consultants05.06.2024
- Wellness Bits of knowledge Readily available: A Survey of \Following Wellbeing and Progress\ Wellness Wearables
- Bold Colors, Playful Shapes, Handmade Textures: This Mexico City Home Is 100% Joyful!
- Weight-loss pill approval set to accelerate food industry product overhauls
- Flu cases spiking this holiday season, CDC data shows
- The ‘Stranger Things’ finale, explained: What happens to Vecna? And why was a key character’s fate left unknown?
- Audits of 6 Specialty Mixed drinks
- The Most Compelling Innovation Developments Somewhat recently
- China’s new condom tax will prove no effective barrier to country’s declining fertility rate
- Merz visit highlights new strategic, and strained, Germany-Israel bond
